Retatrutide, developed by Soma Pharmaceuticals , is gaining increasing attention as a innovative method for metabolic control . This innovative compound integrates the properties of a GLP-1 receptor agonist and a GIP receptor stimulant, intended to simply promote weight loss but also address asso